Fatal familial insomnia (FFI) is an extremely rare autosomal dominant prion disease. The chief clinical features include an organic sleep disorder associated with sympathetic overdrive, motor and bulbar compromise as well as progressive cognitive decline. Death ensures in 100% of cases with a mean survival duration of 18 months from time of symptom onset. Treatment strategies in the management of FFI remains largely symptomatic with greater emphasis placed on palliative care services. We report a case of a 31-year old gentleman (Mr G) who presented with insomnia, sleep behavior disturbances, diplopia, myoclonus and transient global amnesia. A family history of a paternal aunt with similar presentation who passed away raised the suspicion of...
none21siObjective: Comprehensively describe the phenotypic spectrum of sporadic fatal insomnia (sFI)...
Fatal familial insomnia (FFI) is an inherited prion disease linked to a mutation at codon 178 of the...
In 1986, Lugaresi et al. described several patients with an autosomal-dominant neurodegenerative dis...
A previously well 54-?year-old woman presented with a short history of diplopia, cognitive decline, ...
Introduction. Fatal familial insomnia (FFI) is one of the transmissible spongiform encephathalopathi...
In 1986, we reported two anatomoclinical observations of a familial condition that we called "fatal ...
Abstract Background Fatal familial insomnia (FFI) is a rare autosomal dominant disease caused by the...
The authors report a new kindred with fatal familial insomnia (FFI)--an inherited prion disease. The...
The clinical presentation and evolution, neuropathological findings, and genotyp-ing of three member...
This review study was carried out to educate people about a rare genetic disorder that is fatal fami...
BACKGROUND: In absence of a positive family history, the diagnosis of fatal familial insomnia (FFI) ...
Fatal familial insomnia (FFI) is a rare inherited prion disease characterized by sleep, autonomic, a...
This is the author accepted manuscript. The final version is available from BMJ Publishing Group vi...
Fatal Familial Insomnia is a hereditary prion disease characterized by a mutation at codon 178 of th...
Fatal Familial Insomnia (FFI) is an insidious prion disorder that tends to manifest itself as a pati...
none21siObjective: Comprehensively describe the phenotypic spectrum of sporadic fatal insomnia (sFI)...
Fatal familial insomnia (FFI) is an inherited prion disease linked to a mutation at codon 178 of the...
In 1986, Lugaresi et al. described several patients with an autosomal-dominant neurodegenerative dis...
A previously well 54-?year-old woman presented with a short history of diplopia, cognitive decline, ...
Introduction. Fatal familial insomnia (FFI) is one of the transmissible spongiform encephathalopathi...
In 1986, we reported two anatomoclinical observations of a familial condition that we called "fatal ...
Abstract Background Fatal familial insomnia (FFI) is a rare autosomal dominant disease caused by the...
The authors report a new kindred with fatal familial insomnia (FFI)--an inherited prion disease. The...
The clinical presentation and evolution, neuropathological findings, and genotyp-ing of three member...
This review study was carried out to educate people about a rare genetic disorder that is fatal fami...
BACKGROUND: In absence of a positive family history, the diagnosis of fatal familial insomnia (FFI) ...
Fatal familial insomnia (FFI) is a rare inherited prion disease characterized by sleep, autonomic, a...
This is the author accepted manuscript. The final version is available from BMJ Publishing Group vi...
Fatal Familial Insomnia is a hereditary prion disease characterized by a mutation at codon 178 of th...
Fatal Familial Insomnia (FFI) is an insidious prion disorder that tends to manifest itself as a pati...
none21siObjective: Comprehensively describe the phenotypic spectrum of sporadic fatal insomnia (sFI)...
Fatal familial insomnia (FFI) is an inherited prion disease linked to a mutation at codon 178 of the...
In 1986, Lugaresi et al. described several patients with an autosomal-dominant neurodegenerative dis...